Tilt Biotherapeutics raised €6.2M in a Early VC round in Jun 2020. The company is based in Helsinki, Finland. Investors in the round: Business Finland. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €6.2M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
